Education: MBBS (AIIMS), MD Medicine (AIIMS), DM Medical Oncology (AIIMS), Foley Family Leukemia Fellowship (Dana Farber Cancer Institute/Harvard Cancer Center)
Dr. Archana Sasi is a skilled hemato-oncologist with over 5 years of clinical experience in the diagnosis and treatment of a wide range of cancers, and blood cancers in particular. She holds MBBS (AIIMS, New Delhi), MD Medicine (AIIMS, New Delhi), DM Medical Oncology (AIIMS, New Delhi), Member of the Royal College of Physicians (United Kingdom) qualifications and is a Foley Family Leukemia Fellow, trained at the Dana Farber Cancer Institute (Harvard Cancer Center), reflecting her advanced training in hemato-oncology and evidence-based cancer care. Practicing at Apollo Hospitals, Delhi, Dr. Sasi specializes in hemato-oncology, providing comprehensive treatment for hematological malignancies. She is committed to delivering personalized cancer care, including chemotherapy, targeted therapy, bone marrow transplant and cellular therapy, supportive care, and long-term follow-up, with a focus on improving patient outcomes and quality of life. Fluent in English, Hindi, and Malayalam, Dr. Sasi communicates effectively with patients from diverse backgrounds, ensuring they understand their diagnosis and treatment options. Patients seeking expert hemato-oncology care in Delhi can rely on her compassionate, evidence-based approach at Apollo Hospitals, Delhi.
Read More
Ask your query
Special interest
Leukemia and other myeloid malignancies [myelodysplastic syndromes (MDS)
myeloproliferative neoplasms (MPN)
MDS/MPN overlap
Hematopoietic stem cell transplantation
Memberships
American Society of Clinical Oncology, American Society of Hematology
Awards & Achievements
2025: American Society of Hematology Abstract Achievement Award
2024: Awarded the Shakuntala Jolly Medal for the Best Fellow in Medical Oncology at All India Institute of Medical Sciences (AIIMS), New Delhi
2022: Winner of the Prof RK Marwaha-PHO Chapter Travelling Scholarship & Invited speaker at SIOP best paper session at Pediatric Hematology Oncology Conference (PHOCON), New Delhi in 2022
2021: Secured 1st Position in India in the AIIMS DM Entrance Examination (July 2021) in Medical Oncology
2019: Awarded the Kirpal Kaur Medal for the Best House Physician in Medicine at AIIMS, New Delhi during residency
2017: Awarded the Dr Atm-Prakash Medal for Best Intern in Surgery at AIIMS
2017: Secured 1st Position in India in the AIIMS Post Graduate Medical Entrance Examination
2017: Received scholarship and certificate of merit from AIIMS for 3rd position in the batch
2016: Awarded the Gold Medal and Sorel Catherine Freyman Book Prize in Paediatrics for securing first position in the class at AIIMS, New Delhi
2014: Awarded the Gold Medal in Pharmacology for securing first position in the class at AIIMS, New Delhi
2014: Awarded the Gold Medal and the Sardari Lal Kalra Medal in Microbiology for securing first position in the class at AIIMS, New Delhi
2012: Secured All India Rank 1 in AIIMS Entrance Examination, JIPMER Entrance, Karnataka CET, COMED-K and KMC Manipal entrances
Research & Publications
01
Over 40 PubMed indexed publications in oncology with h-index of 10. A representative list of publications is provided below: Kumar RR, Sharma U, Shree A, Chaudhary S, Ganguly S, Bakhshi R, Singh A, Palanichamy JK, Sahoo RK, Batra A, Sharawat SK, Pushpam D, Chopra A, Sasi A, Bakhshi S. Mitophagy-driven prognosis in pediatric acute myeloid leukemia: a new frontier. Sci Rep. 2026 Mar 3;16(1):11920. doi: 10.1038/s41598-026-42399-x. PMID: 41775860; PMCID: PMC13066364.
02
Ganguly S, Sasi A, Pushpam D, Bakhshi S. Philadelphia Chromosome Positive and Philadelphia-Like Acute Lymphoblastic Leukemia in Children and Adolescents: Current Management, Controversies and Emerging Concepts. Indian J Pediatr. 2024 Jan;91(1):37-46. doi: 10.1007/s12098-023-04782-8. Epub 2023 Aug 26. PMID: 37632689.
03
Ganguly S, Sasi A, Nagaraju SKK, Bakhshi S. Anti-Emetics in Children Receiving Chemotherapy for Solid Tumors and Leukemia: Pharmacology and Optimization of Therapy for Nausea and Vomiting. Pharmaceuticals (Basel). 2024 May 10;17(5):616. doi: 10.3390/ph17050616. PMID: 38794186; PMCID: PMC11124061.
04
Shimony S, Murdock HM, Keating J, Tsai HK, Sasi A, Gibson CJ, Faderl S, Wagner A, Dronamraju N, Lin TL, Prebet T, Cortes JE, Uy GL, Lancet JE, Reilly CR, Neuberg D, Stone RM, Lindsley RC. CPX-351 selectively benefits patients with AML and myelodysplasia-related mutations in the pivotal randomized trial. Blood Adv. 2026 Apr 28;10(8):2854-2864. doi: 10.1182/bloodadvances.2025019378. PMID: 41628350; PMCID: PMC13133533.
Best Hospital Near me Chennai